Fintech Investors & VC Firms in United States
667 firms in this list, with a median first check of $500K. 69 of them lead rounds. Generated from verified public data and updated continuously.
FirstMark Capital
New YorkPre-Seed–Series B$250K – $10M
11 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage
37 people
Spark Capital
San FranciscoSeed–Late Stage$500K – $25M
26 people
Maven 11
AmsterdamPre-Seed–Series A
21 people
Rally Ventures Management, Llc
Menlo ParkPre-Seed–Series A$100K – $4M
14 people
Mercury Fund
HoustonSeed–Series A$250K – $4M
18 people
Expansion Venture Capital
New YorkPre-Seed–Series A
4 people
DN Capital
LondonSeed–Growth$100K – $20M
40 people
Founders Factory
LondonPre-Seed–Seed
37 people
Bling Capital
Miami BeachSeed–Series A$1M – $5M
5 people
March Capital Partners
Santa MonicaGrowth–Late Stage
32 people
IGNIA
Mexico CityPre-Seed–Series A$100K – $5M
21 people
Presidio Ventures
Silicon ValleySeed–Series A$500K – $5M
24 people
Forerunner Ventures
San FranciscoSeed–Late Stage$1M – $20M
6 people
Link Ventures
CambridgePre-Seed–Late Stage
23 people
The Argentum Group
New YorkGrowth–Late Stage
9 people
Great Oaks Venture Capital
New YorkPre-Seed–Series A$50K – $500K
5 people
The Hive
Santa MonicaPre-Seed–Series C$1.5M – $3M
43 people
FINTOP Capital
NashvilleSeed–Series B
20 people
XRC
AikenPre-Seed–Series A
19 people
Suffolk Technologies
BostonSeed–Series B
15 people
Black Dragon Capital
MiamiGrowth–Late Stage
40 people
Upper90
ProvidenceSeed–Series B$5M – $25M
23 people
MatterScale Ventures
São PauloPre-Seed–Series A$150K – $750K
29 people
Related lists
Crypto & Web3 Investors & VC Firms (3508)Investors & VC Firms in United States (2647)SaaS Investors & VC Firms (1992)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1451)Healthtech Investors & VC Firms (1329)Consumer Investors & VC Firms (1245)Fintech Seed Investors & VC Firms (1191)Fintech Series A Investors & VC Firms (1147)Biotech Investors & VC Firms (1139)
Data sourced from public filings and firms' own websites — see our methodology.

























